Host gene expression profiling in influenza A virus-infected lung epithelial (A549) cells: A comparative analysis between highly pathogenic and modified H5N1 viruses

Virology Journal

Volumn 7, Issue , 2010, Pages

  Chakrabarti, Alok K ^a   Vipat, Veena C ^a   Mukherjee, Sanjay ^a   Singh, Rashmi ^a   Pawar, Shailesh D ^a   Mishra, Akhilesh C ^a  

^a NATIONAL INSTITUTE OF VIROLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT VACCINE; VIRUS VACCINE; INFLUENZA VACCINE; LIVE VACCINE;

APOPTOSIS; ARTICLE; AVIAN INFLUENZA VIRUS; CANCER CELL CULTURE; CELL STRAIN; CELL STRAIN A549; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA MODIFICATION; GENE EXPRESSION PROFILING; GENETIC ANALYSIS; HOST RESISTANCE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFLAMMATION; INFLUENZA A (H5N1); INFLUENZA VIRUS A; LUNG ALVEOLUS CELL; MICROARRAY ANALYSIS; MOLECULAR DYNAMICS; NONHUMAN; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; VIRUS CELL INTERACTION; VIRUS PATHOGENESIS; VIRUS VIRULENCE; CELL LINE; EPITHELIUM CELL; GENETIC RECOMBINATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HOST PATHOGEN INTERACTION; INFLUENZA VIRUS A H5N1; PATHOGENICITY; TIME; VIROLOGY;

AVES; AVIAN INFLUENZA VIRUS; INFLUENZA A VIRUS;

CELL LINE; EPITHELIAL CELLS; GENE EXPRESSION PROFILING; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA VACCINES; RECOMBINATION, GENETIC; TIME FACTORS; VACCINES, ATTENUATED;

EID: 77956472598     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-7-219     Document Type: Article

References (26)

1. Cumulative number of confirmed human cases of avian influenza A/(H5N1) reported to WHO. World Health Organization, 2010 Geneva, Switzerland. http://www.who.int/csr/disease/avian-influenza/country/cases-table-2010-05-06/ en/index.html
2. Preparing for the Next Pandemic. Michael T Osterholm, NEJM 2005 352 18 10.1056/NEJMp058068 (Pubitemid 40627807)
3. Avian influenza: A review. JK Thomas J Noppenberger, Am J Health Syst Pharm 2007 64 149 165 10.2146/ajhp060181 17215466
4. The polymerase complex genes contribute to the high virulence of the human H5N1 influenza virus isolate A/Vietnam/1203/04. RR Salomon J Franks EA Govorkova NA Ilyushina H Yen DJ Hulse-Post J Humberd M Trichet JE Rehg RJ Webby RG Webster E Hoffmann, JEM 2006 203 3 689 697 10.1084/jem.20051938
5. Innate immune responses to influenza A H5N1: friend or foe? JS Peiris CY Cheung CY Leung JM Nicholls, Trends in Immunology 2009 30 12 574 584 10.1016/j.it.2009.09.004 19864182
6. Pathogenesis of emerging avian influenza viruses in mammals and the host innate immune response. TR Maines KJ Szretter L Perrone JA Belser RA Bright H Zeng TM Tumpey JM Katz, Immunological Reviews 2008 225 1 68 84 10.1111/j.1600-065X.2008.00690.x 18837776
7. Cytokine storm in avian influenza. D Us, Mikrobiyol Bul 2008 42 2 365 80 18697437
8. Early host responses to avian influenza A virus are prolonged and enhanced at transcriptional level depending on maturation of the immune system. SS Reemers D Leenen MJ Koerkamp D Haarlem P Haar W Eden L Vervelde, Mol Immun 2010 47 1675 1685 10.1016/j.molimm.2010.03.008
9. Avian influenza virus signaling: implications for the disease severity of H5N1 infection. DC Lee ASY Lau, Signal Transduction 2007 7 1 64 80 10.1002/sita.200600117 (Pubitemid 46326744)
10. System-level comparison of host-responses elicited by avian H5N1 and seasonal H1N1 influenza viruses in primary human macrophages. SM Lee JL Gardy CY Cheung TK Cheung KP Hui NY Ip Y Guan RE Hancock JSM Peiris, PLoS One 2009 4 12 8072 10.1371/journal.pone.0008072 20011590
11. Gene Expression Analysis of host innate immune responses during lethal H5N1 infection in ferrets. CM Cameron MJ Cameron JF Bermejo-Martin L Ran L Xu PV Turner R Ran A Danesh Y Fang PM Chan N Mytle TJ Sullivan TL Collins MG Johnson JC Medina T Rowe DJ Kelvin, J Virol 2008 82 22 11308 11317 10.1128/JVI.00691-08 18684821
12. Expression of RANTES by normal airway epithelial cells after influenza virus A infection. S Matsukura F Kokubu H Kubo T Tomita H Tokunaga M Kadukora T Yamamoto Y Kuroiwa T Ohno H Suzaki M Adachi, Ann J Respir Cell Mol Biol 1998 18 255 264
13. Inhibition of the cytokine response does not protect against lethal H5N1 influenza infection. R Salomon E Hoffmann RG Webster, PNAS 2007 104 30 12479 12481 10.1073/pnas.0705289104 17640882
14. Tropism of avian influenza A (H5N1) in the upper and lower respiratory tract. JM Nicholls MC Chan WY Chan HK Wong CY Cheung, et al. Nat Med 2007 13 147 149 10.1038/nm1529 17206149
15. Characterization of the Influenza A H5N1 Viruses of the 2008-09 Outbreaks in India reveals a third introduction and possible endemicity. AK Chakrabarti SD Pawar SS Cherian SS Koratkar SM Jadhav B Pal S Raut V Thite SS Kode SS Keng BJ Payyapilly J Mullick AC Mishra, PLoS One 2009 4 11 7846 10.1371/journal.pone. 0007846 19924254
16. Availability of a new recombinant A(H5N1) vaccine virus. World Health Organization, Geneva, Switzerland 2010 http://www.who.int/csr/disease/avian- influenza/H5N1virusJuly/en/index.html
17. Live Attenuated Influenza Viruses Containing NS1 Truncations as Vaccine Candidates against H5N1 Highly Pathogenic Avian Influenza. J Steel AC Lowen L Pena M Angel A Solo'rzano R Albrecht DR Perez A García-Sastre P Palese, J Virology 2009 83 4 1742 1753 10.1128/JVI.01920-08 19073731
18. Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells. MCW Chan CY Cheung WH Chui SW Tsao JM Nicholls YO Chan RWY Chan HT Long LLM Poon Y Guan JM Peiris, Respiratory Research 2005 6 135 137 10.1186/1465-9921-6-135 16283933
19. Global Host Immune Response: Pathogenesis and Transcriptional Profiling of Type A Influenza Viruses Expressing the Hemagglutinin and Neuraminidase Genes from the 1918 Pandemic Virus. JC Kash CF Basler A García-Sastre V Carter R Billharz DE Swayne M Ronald RM Przygodzki K Jeffery JK Taubenberger MG Katze TM Tumpey, J Virology 2004 78 17 9499 9511 10.1128/JVI.78.17.9499-9511.2004 15308742
20. Cytokine production through PKC/p38 signaling pathways, not through JAK/STAT1 pathway, in mast cells stimulated with IFN gamma. JY Seo DY Kim YS Lee JY Ro, Cytokine 2009 46 1 51 60 10.1016/j.cyto.2008.12.008 19231233
21. Type I interferons and interferon regulatory factors regulate TNF-related apoptosis-inducing ligand (TRAIL) in HIV-1-infected macrophages. Y Huang A Walstrom L Zhang Y Zhao M Cui L Ye JC Zheng, PLoS One 2009 4 4 5397 10.1371/journal.pone.0005397 19404407
22. Essential Impact of NF-kappaB Signaling on the H5N1 Influenza A Virus-Induced Transcriptome. M Schmolke D Dorothee Viemann J Johannes Roth S Ludwig, J Immunol 2009 183 5180 5189 10.4049/jimmunol.0804198 19786538
23. Human host factors required for influenza virus replication. R Konig S Stertz Y Zhou A Inoue H Hoffmann S Bhattacharyya JG Alamares DM Tscherne MB Ortigoza Y Liang Q Gao S Andrews S Bandyopadhyay PD Jesus BP Tu, et al. Nature 2009 463 11 813 17
24. Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus. CR Baskin H Bielefeldt-Ohmann TM Tumpey PJ Sabourin JP Long, et al. Proc Natl Acad Sci USA 2009 106 3455 3460 10.1073/pnas.0813234106 19218453
25. Highly pathogenic avian influenza A virus H5N1 NS1 protein induces caspase-dependent apoptosis in human alveolar basal epithelial cells. C Zhang Y Yang X Zhou X Liu H Song Y He P Huang, Virology Journal 2010 7 51 54 10.1186/1743-422X-7-51 20196872
26. Apoptosis and Pathogenesis of Avian Influenza A (H5N1) Virus in Humans. M Uiprasertkul R Kitphati P Puthavathana R Kriwong A Kongchanagul K Ungchusak S Angkasekwinai K Chokephaibulkit K Srisook N Vanprapar P Auewarakul, Emerging Infectious diseases online 2007 13 5 708 712 http://www.cdc.gov/eid (Pubitemid 46698732)